Rocuronium Injection, Solution
Product Images NDC 65219-442

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Rocuronium (NDC 65219-442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Roc09 0003 01)

Chemical structure of rocuronium bromide, showing its steroidal core with distinctive ring formations, functional groups including hydroxyl and ester moieties, and a quaternary ammonium group indicated by a positive charge paired with a bromide anion.*

FDA Label Image

Figure 1 (Roc09 0003 02)

Box plot chart depicting Rocuronium injection effect durations in minutes across different age groups (18-64 years, 65 years and older, and 1-12 years) and dosages (0.45, 0.6, 0.9, 1.2 mg/kg). The vertical axis represents time in minutes, showing variability and median response times at each dosage and age category.*

FDA Label Image

Figure 2 (Roc09 0003 03)

A box-and-whisker plot showing variability in drug effect or measurement related to Rocuronium Bromide injection. The x-axis represents age groups and dosages in mg/kg, and the y-axis shows time in minutes. The plot compares response duration across different age categories from 1-12 years up to 18-64 years.*

FDA Label Image

Figure 3 (Roc09 0003 04)

A line graph depicting the relationship between dose number and time in minutes for two dose levels, 0.1 mg/kg and 0.15 mg/kg. The x-axis represents dose number from 0 to 6, and the y-axis represents time in minutes up to 30. Two separate lines are plotted, with respective sample sizes of N=29 for 0.1 mg/kg and N=13 for 0.15 mg/kg dose levels.*

FDA Label Image

Fresenius Kabi Logo (Roc09 0003 05)

FDA Label Image

Vial (Roc09 0003 06)

Rocuronium Bromide Injection 50 mg per 5 mL (10 mg per mL) single-dose vial label. The label warns this is a paralyzing agent causing respiratory arrest and is for intravenous use only. It includes storage instructions and manufacturer information for Fresenius Kabi USA, LLC in Lake Zurich, IL.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Rocuronium Bromide Injection 10 mg/mL solution in 5 mL single-dose vials, supplied as 10 vials per package. The label includes a warning about its paralyzing agent effects and respiratory arrest risk. Manufactured by Fresenius Kabi USA, LLC in Lake Zurich, IL, for intravenous use only.*

FDA Label Image

100vial (Roc09 0003 08)

Label for Rocuronium Bromide Injection, 10 mg/mL (100 mg per 10 mL) in a 10 mL single-dose vial. The label includes warnings about the product as a paralyzing agent for intravenous use only. It also provides storage instructions and manufacturer information for Fresenius Kabi USA, LLC in Lake Zurich, IL.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Rocuronium Bromide Injection 10 mg/mL by Fresenius Kabi USA, LLC. This solution is packaged as 100 mg per 10 mL in single-dose vials for intravenous use only. The label includes a warning about its paralyzing effects and need for artificial respiration, storage instructions, and inactive ingredients.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Rocuronium Bromide Injection, 10 mg/mL (50 mg per 5 mL) single-dose vial by Fresenius Kabi USA, LLC. The sterile, nonpyrogenic intravenous solution includes a warning of its paralyzing agent effect causing respiratory arrest, requiring facilities to have artificial respiration available. Storage instructions and ingredient details are also provided.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Rocuronium Bromide Injection 10 mg/mL label for intravenous use. The label indicates 50 mg per 5 mL vials, provided as 10 single-dose 5 mL vials. It includes warnings about the drug being a paralyzing agent requiring facilities for artificial respiration. Labeler is Fresenius Kabi USA, LLC, with storage and usage instructions.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Rocuronium Bromide Injection 10 mg/mL single-dose vial label by Fresenius Kabi USA, LLC. The 10 mL vial contains 100 mg total of Rocuronium Bromide. The label includes warnings that it is a paralyzing agent requiring respiratory support, storage instructions, dosage note, and a barcode with NDC 65219-697-01.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Rocuronium Bromide Injection, 10 mg/mL strength, in a 10 mL single-dose vial. The label states the product is a paralyzing agent for intravenous use only, with a warning about respiratory arrest. It is labeled by Fresenius Kabi USA, LLC, including storage instructions and a website URL, plus a barcode and NDC 65219-697-10.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Rocuronium Bromide Injection, a paralyzing agent with a concentration of 10 mg per mL, intended for intravenous use. The label includes fields for date, time, and initials for application to a syringe. It is marked for prescription use only and produced by Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.